Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pure Bioscience (PURE)

Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 7,830
  • Shares Outstanding, K 111,856
  • Annual Sales, $ 1,880 K
  • Annual Income, $ -3,960 K
  • 60-Month Beta 0.07
  • Price/Sales 4.18
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade PURE with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.06
  • Most Recent Earnings $-0.01 on 03/18/24
  • Latest Earnings Date 06/12/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0630 +11.11%
on 04/16/24
0.0990 -29.29%
on 04/02/24
-0.0290 (-29.29%)
since 03/25/24
3-Month
0.0630 +11.11%
on 04/16/24
0.1260 -44.44%
on 01/26/24
-0.0499 (-41.62%)
since 01/25/24
52-Week
0.0630 +11.11%
on 04/16/24
0.1670 -58.08%
on 12/13/23
-0.0029 (-3.98%)
since 04/25/23

Most Recent Stories

More News
PURE Bioscience Reports Fiscal 2023 Second Quarter And Six-Month Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for the fiscal second quarter and six-month period...

PURE : 0.0700 (unch)
PURE Bioscience Reports Fiscal First Quarter 2023 Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for...

PURE : 0.0700 (unch)
PURE Bioscience Reports Fiscal 2022 Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for...

PURE : 0.0700 (unch)
PURE Bioscience Reports Fiscal 2022 Third Quarter and Nine-Month Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for the fiscal third quarter and nine-month period...

PURE : 0.0700 (unch)
PURE Bioscience Reports Fiscal 2022 Second Quarter And Six-Month Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for the fiscal second quarter and six-month period...

PURE : 0.0700 (unch)
PURE Bioscience Reports Fiscal First Quarter 2022 Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ) (the “Company,” “PURE” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for...

PURE : 0.0700 (unch)
PURE Bioscience Reports Fiscal 2021 Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ) (the “Company,” “PURE” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for...

PURE : 0.0700 (unch)
PURE Bioscience Reports Fiscal 2021 Second Quarter And Six-Month Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for the fiscal second quarter and six-month period...

PURE : 0.0700 (unch)
PURE Bioscience and LightHouse for the Blind and Visually Impaired – San Francisco Announce Successful Completion of FAA Evaluation

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, and its General Services Administration (GSA) and AbilityOne partner LightHouse...

PURE : 0.0700 (unch)
PURE Bioscience Welcomes New Members to Board of Directors and Scientific Advisory Board

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today announced the addition of three new members to the Board of Directors with...

PURE : 0.0700 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

PURE Bioscience develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including methicillin-resistant Staphylococcus aureus (MRSA), or staph infection. PURE's proprietary high efficacy/low toxicity bioscience technologies, including its...

See More

Key Turning Points

3rd Resistance Point 0.0700
2nd Resistance Point 0.0700
1st Resistance Point 0.0700
Last Price 0.0700
1st Support Level 0.0700
2nd Support Level 0.0700
3rd Support Level 0.0700

See More

52-Week High 0.1670
Fibonacci 61.8% 0.1273
Fibonacci 50% 0.1150
Fibonacci 38.2% 0.1027
Last Price 0.0700
52-Week Low 0.0630

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar